The Company is a Korea-based company is mainly engaged in the clinical trial agency and drug development business. The Company is mainly engaged in the provision of comprehensive early-stage clinical services in the areas of medical writing, regulatory matters, data management, biostatistics and others. The Company is mainly engaged in the provision of consulting services including initial clinical development, clinical trial development, global clinical trial development and others. In addition, the Company is also engaged in the operation of clinical trial training center. The Company was established on June 18, 2020. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on September 23, 2020.
Headquarters
C R Bldg., 412, Yeoksam-Ro, Gangnam-Gu
Seoul; Seoul;
Contact Details: Purchase the C&R Research Inc. (Seoul) report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service